A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...
AbbVie closed out the year on a high note, as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s ...
During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback